LIQUID-PHASE COMPOSITION CONTAINING ALGINIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND COLLOIDAL POLYSACCHARIDE

The present invention relates to a liquid composition including alginic acid or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide. The liquid composition of the present invention is suitable as a medical biomaterial for tissue repair to elevate mucosal tissues of the stomach...

Full description

Saved in:
Bibliographic Details
Main Authors LEE, Eun Jung, LEE, Cheol Woo
Format Patent
LanguageEnglish
French
German
Published 07.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a liquid composition including alginic acid or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide. The liquid composition of the present invention is suitable as a medical biomaterial for tissue repair to elevate mucosal tissues of the stomach and intestines during endoscopic resection. More specifically, the present invention relates to a submucosal injectable pharmaceutical liquid composition for use in endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) for medical applications, including alginic acid having a weight average molecular weight of 100,000 to less than 200,000 or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide. The liquid composition of the present invention is suitable for use as a preparation for submucosal local injection that can maintain mucosal elevation for a long time when injected during endoscopic mucosal resection or endoscopic submucosal dissection.
Bibliography:Application Number: EP20180818009